[
Aged
Antigens, Surface
/ metabolism
Antineoplastic Agents, Hormonal
/ therapeutic use
Fluorine Radioisotopes
Glutamate Carboxypeptidase II
/ metabolism
Humans
Kallikreins
/ blood
Male
Neoplasm Recurrence, Local
/ diagnostic imaging
Neoplasm Staging
Positron Emission Tomography Computed Tomography
/ methods
Prostate-Specific Antigen
/ blood
Prostatic Neoplasms
/ diagnostic imaging
Radiopharmaceuticals
/ pharmacokinetics
Retrospective Studies
Androgen deprivation therapy
PET
PSMA
Prostate cancer
[18F]-JK-PSMA-7
Journal
Molecular imaging and biology
ISSN: 1860-2002
Titre abrégé: Mol Imaging Biol
Pays: United States
ID NLM: 101125610
Informations de publication
Date de publication:
04 2021
04 2021
Historique:
received:
03
06
2020
accepted:
18
09
2020
revised:
13
09
2020
pubmed:
3
10
2020
medline:
16
11
2021
entrez:
2
10
2020
Statut:
ppublish
Résumé
PSMA imaging is frequently used for monitoring of androgen deprivation therapy (ADT) in prostate cancer. In a previous study, [ We examined the performance of [ In the first cohort, we detected [ [
Identifiants
pubmed: 33006028
doi: 10.1007/s11307-020-01546-0
pii: 10.1007/s11307-020-01546-0
pmc: PMC7910246
doi:
Substances chimiques
Antigens, Surface
0
Antineoplastic Agents, Hormonal
0
Fluorine Radioisotopes
0
Radiopharmaceuticals
0
FOLH1 protein, human
EC 3.4.17.21
Glutamate Carboxypeptidase II
EC 3.4.17.21
KLK3 protein, human
EC 3.4.21.-
Kallikreins
EC 3.4.21.-
Prostate-Specific Antigen
EC 3.4.21.77
Fluorine-18
GZ5I74KB8G
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
277-286Références
J Nucl Med. 2019 Jul;60(7):950-954
pubmed: 30552200
N Engl J Med. 2019 Jul 11;381(2):121-131
pubmed: 31157964
Clin Nucl Med. 2019 Jul;44(7):582-584
pubmed: 31058686
J Nucl Med. 2020 May;61(5):729-734
pubmed: 31628219
Eur J Nucl Med Mol Imaging. 2020 Jan;47(1):136-146
pubmed: 31492993
J Nucl Med. 2018 Mar;59(3):469-478
pubmed: 29123012
Eur J Nucl Med Mol Imaging. 2020 Mar;47(3):632-641
pubmed: 31732768
Eur J Nucl Med Mol Imaging. 2017 Apr;44(4):678-688
pubmed: 27889802
J Nucl Med. 2019 Jun;60(6):817-823
pubmed: 30389823
Eur J Nucl Med Mol Imaging. 2020 Jan;47(1):9-15
pubmed: 31654093
Eur J Nucl Med Mol Imaging. 2020 Mar;47(3):665-673
pubmed: 31879814
Mol Imaging Biol. 2015 Aug;17(4):575-84
pubmed: 26013479
J Nucl Med. 2017 Jun;58(6):947-952
pubmed: 27908968
Int Braz J Urol. 2019 May-Jun;45(3):459-467
pubmed: 30901173
EJNMMI Res. 2019 Jul 25;9(1):66
pubmed: 31346821
J Nucl Med. 2020 Feb;61(2):202-209
pubmed: 31324713
Eur J Nucl Med Mol Imaging. 2020 Mar;47(3):687-694
pubmed: 31901103
J Nucl Med. 2018 Mar;59(3):479-485
pubmed: 28887401
Eur J Nucl Med Mol Imaging. 2018 Nov;45(12):2045-2054
pubmed: 29980832
Clin Cancer Res. 2019 Dec 15;25(24):7448-7454
pubmed: 31511295